Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Sevelamer
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sevelamer 800mg tablets
0905022S0AAABAB
|
Sevelamer | Sevelamer | Nutrition and Blood | 21,894 |
|
Renagel 800mg tablets
0905022S0BBABAB
|
Renagel | Sevelamer | Nutrition and Blood | 866 |
|
Renvela 800mg tablets
0905022S0BCAAAB
|
Renvela | Sevelamer | Nutrition and Blood | 590 |
|
Sevelamer 2.4g oral powder sachets sugar free
0905022S0AAACAC
|
Sevelamer | Sevelamer | Nutrition and Blood | 269 |
|
Sevelamer 800mg oral powder sachets sugar free
0905022S0AAAEAE
|
Sevelamer | Sevelamer | Nutrition and Blood | 221 |
|
Renvela 2.4g oral powder sachets
0905022S0BCABAC
|
Renvela | Sevelamer | Nutrition and Blood | 106 |
|
Renvela 0.8g oral powder sachets
0905022S0BCACAE
|
Renvela | Sevelamer | Nutrition and Blood | 18 |
|
Sevelamer 400mg tablets
0905022S0AAADAD
|
Sevelamer | Sevelamer | Nutrition and Blood | 1 |
|
Renagel 403mg capsules
0905022S0BBAAAA
|
Renagel | Sevelamer | Nutrition and Blood | No data available |
|
Sevelamer 403mg capsules
0905022S0AAAAAA
|
Sevelamer | Sevelamer | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.